Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Bexarotene | |
| Synonyms |
|
|
| Definitions |
A synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties. Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C1635 |
|
| Accepted_Therapeutic_Use_For |
Oral or topical treatment of cutaneous manifestations of cutaneous T-cell lymphoma (CTCL).
|
|
| ALT_DEFINITION |
A drug used to treat skin problems caused by cutaneous T-cell lymphoma that have not gotten better after other treatment. It is also being studied in the treatment of other types of cancer. Bexarotene is a type of retinoid.
|
|
| CAS_Registry |
153559-49-0
|
|
| CHEBI_ID |
CHEBI:50859
|
|
| Chemical_Formula |
C24H28O2
|
|
| code |
C1635
|
|
| Contributing_Source |
CTRP FDA
|
|
| definition |
A synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties. Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression. (NCI04)
|
|
| Display_Name |
Bexarotene
|
|
| FDA_UNII_Code |
A61RXM4375
|
|
| Has_Target | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C116977 http://purl.obolibrary.org/obo/NCIT_C116978 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
| Is_Value_For_GDC_Property | ||
| label |
Bexarotene
|
|
| Legacy Concept Name |
Bexarotene
|
|
| Maps_To |
Bexarotene
|
|
| NCI_Drug_Dictionary_ID |
42117
|
|
| PDQ_Closed_Trial_Search_ID |
42117
|
|
| PDQ_Open_Trial_Search_ID |
42117
|
|
| Preferred_Name |
Bexarotene
|
|
| prefixIRI |
NCIT:C1635
|
|
| prefLabel |
Bexarotene
|
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
| UMLS_CUI |
C0765273
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping